Form 4 for MMSI MERIT MEDICAL SYSTEMS INC
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001415889-25-006309 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-02-27+ | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | A - Grant | $0.00 | +51.1K | 1.11M | +5% | $0 |
| DM | 2025-03-03 | 2025-02-27+ | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | F - Tax | $100.83 | -39.5K | 1.12M | -3% | -$3.99M |
| DI | 2025-03-03 | 2025-02-28 | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | F - Tax | $102.04 | -2,494 | 10.7K | -19% | -$254.5K |
| DI | 2025-03-03 | 2025-02-28 | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | M - OptEx | $44.80 | +4,000 | 13.2K | +43% | +$179.2K |
| D | 2025-03-03 | 2025-02-28 | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | M - OptEx | $44.80 | +38.0K | 1.14M | +3% | +$1.70M |
| DI | 2025-03-03 | 2025-02-28 | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | M - OptEx | $0.00 | -4,000 | 0 | -100% | $0 |
| D | 2025-03-03 | 2025-02-28 | MMSI | LAMPROPOULOS FRED P | Pres, CEO, Dir | M - OptEx | $0.00 | -38.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, No Par Value | 2025-02-27 | A | A | 30,755 | $0.00 | 1,098,506 | D | — | — | (F3) These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2022. |
| 2 | Common | Common Stock, No Par Value | 2025-02-27 | F | D | 13,501 | $98.50 | 1,085,005 | D | — | — | (F4) The Reporting Person surrendered 13,051 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market. |
| 3 | Common | Common Stock, No Par Value | 2025-02-28 | A | A | 20,384 | $0.00 | 1,105,389 | D | — | — | (F5) Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting. |
| 4 | Common | Common Stock, No Par Value | 2025-02-28 | F | D | 2,494 | $102.04 | 10,734 | I By spouse | — | — | (F7) The Reporting Person's spouse surrendered 2,494 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market. (F2) Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| 5 | Common | Common Stock, No Par Value | 2025-02-28 | F | D | 26,043 | $102.04 | 1,117,348 | D | — | — | (F6) The Reporting Person surrendered 26,043 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market. |
| 6 | Common | Common Stock, No Par Value | 2025-02-28 | M | A | 4,000 | $44.80 | 13,228 | I By spouse | — | — | (F2) Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| 7 | Common | Common Stock, No Par Value | 2025-02-28 | M | A | 38,002 | $44.80 | 1,143,391 | D | — | — | |
| 8 | Derivative | Non-qualified stock options (right to buy) | 2025-02-28 | M | D | 4,000 | $0.00 | 0 | I By spouse | $44.80 · 2019-03-02 to 2025-03-02 | 4,000 Common Stock | (F2) Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. (F9) Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited. |
| 9 | Derivative | Non-qualified stock options (right to buy) | 2025-02-28 | M | D | 38,002 | $0.00 | 0 | D | $44.80 · 2019-03-02 to 2025-03-02 | 38,002 Common Stock | (F8) Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. |